We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A case of cryopyrin-associated periodic fever syndrome during canakinumab administration complicated by inflammatory bowel disease.
- Authors
Yamasaki, Yuichi; Kubota, Tomohiro; Takei, Syuji; Imanaka, Hiroyuki; Nonaka, Yukiko; Kawano, Yoshifumi
- Abstract
Cryopyrin-associated periodic fever syndrome (CAPS) is a highly debilitating disorder, which is characterized by unregulated interleukin-1β production driven by autosomal dominantly inherited mutations in the NLRP3 gene. Patients with CAPS often present with early-onset episodes of fever and rash. These patients also present with variable systemic signs and symptoms, such as arthritis, sensorineural hearing loss, chronic aseptic meningitis, and skeletal abnormalities, but minimal gastrointestinal symptoms. Recently, effective therapies for CAPS targeted against interleukin-1 have become available. We report a case of a young Japanese woman with CAPS who developed inflammatory bowel disease during canakinumab therapy. The patient had colostomy after intestinal perforation and changed canakinumab to infliximab. To the best of our knowledge, this is the first report of a case of inflammatory bowel disease secondary to CAPS complicated by gastrointestinal symptoms and arthritis which canakinumab could not control. Patients with CAPS who have symptoms that cannot be controlled by canakinumab should be considered for possible co-morbidities.
- Subjects
INFLAMMATORY bowel diseases; CRYOPYRIN-associated periodic syndromes; INTESTINAL perforation; SYMPTOMS; SKELETAL abnormalities; JAPANESE women
- Publication
Clinical Rheumatology, 2021, Vol 40, Issue 1, p393
- ISSN
0770-3198
- Publication type
Article
- DOI
10.1007/s10067-020-05267-1